Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Chul So Moon

Chul So Moon

Chief Executive Officer
Cangen Biotechnologies, Inc.


Chul So Moon, MD,Ph.D serves as Chief Executive Officer, Chief Science Officer, Advisor and Director of Cangen Biotechnologies, Inc. Dr. Moon has a tenure track Professorship in the Department of Oncology, Otolaryngology, Head and Neck Surgery at The Johns Hopkins University School of Medicine. He is an experienced principal investigator, attending physician, and member of multiple multidisciplinary treatment programs. He served as co-principal investigator of ONXY-015 gene therapy program for advanced head/neck and lung cancer, MD Anderson Cancer Center, Houston, TX. He serves as a Director of Cangen Biotechnologies, Inc. Dr. Moon holds medical licenses in the United States and in Korea. He is a well respected lecturer and author of numerous academic publications. Dr. Moon received his MD from Seoul National University, School of Medicine; his Ph.D. in human genetics and molecular biology from Johns Hopkins University School of Medicine, Baltimore, MD; completed a combined residency in internal medicine as a short track from Pitt County Memorial Hospital, University of North Carolina Systems and MD Anderson Cancer Center, Division of Medicine, Houston, TX; completed a medical oncology and hematology fellowship-clinical training in MD Anderson Cancer Center, Houston, TX.

Research Interest

Cancer gene therapy